SBIR Phase II: Zero Trust Solution for Precision Medicine and Precision Health Data Exchanges
SBIR 第二阶段:精准医疗和精准健康数据交换的零信任解决方案
基本信息
- 批准号:2226026
- 负责人:
- 金额:$ 98.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Cooperative Agreement
- 财政年份:2024
- 资助国家:美国
- 起止时间:2024-04-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
This Small Business Innovation Research (SBIR) Phase II project leverages novel converging technologies and expands blockchain technology to new healthcare domains enabling the secure exchange of confidential, precision health information such as advanced directives and life-sustaining management within and between organizations. The confidentiality, security, and efficiency of data management are critically important in advanced care and life-sustaining treatment decision pathways for ethical, clinical, regulatory, and legal reasons. The combination of the proprietary blockchain solution with artificial intelligence (AI) capabilities and edge computing enablement offers enhanced privacy and security, improved audit-readiness, better risk management, and superior operational efficiency. The solution functions as an overlay to legacy systems. It easily integrates with existing information management systems, in the cloud or on premise. Further, this solution is scalable, providing a competitive advantage and ease of adoption for stakeholders, including those who are seeking Web 3.0 upward compatibility. In addition to the direct impact within this application area, the technology can have a broader positive influence on the economy and society by preventing or reducing data breaches, increasing trust and quality of life, and reducing the total cost of healthcare. This SBIR Phase II project establishes a novel, efficient, and effective solution for advanced directives and life-sustaining management, which is one of the critical areas within precision health and medicine given the highly personalized and ethically-complex nature of the application. The zero-trust solution achieves decentralized confidentiality, fine-grained access control, and robust intrusion tolerance by avoiding any single point of failure and maintaining operational efficiency. By leveraging modern cryptographic protocols, pre-built privacy-preserving smart contracts, advanced user access control overlays, support for publish/subscribe messaging patterns, integration with off-chain operations, and confidentiality-preserving machine learning models, the solution offers a unique, modular, decentralized architecture that can meet complex regulatory, privacy and security requirements. Further, the technology is specifically designed to address Internet of Things (IoT) network security and data management at scale. The project aims to reduce cyber-vulnerability, increase operational flexibility and achieve scalability that will prove beneficial to a broad array of related healthcare and precision medicine domains such as transplant services, genomic medicine, or biobanks where data confidentiality is of critical importance, especially as these are highly vulnerable to data breaches and cyberattacks.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
这个小型企业创新研究(SBIR)第二阶段项目利用了新的融合技术,并将区块链技术扩展到新的医疗保健领域,使组织内部和组织之间能够安全交换机密,精确的健康信息,如高级指令和生命维持管理。出于伦理、临床、监管和法律的原因,数据管理的机密性、安全性和效率在高级护理和维持生命的治疗决策途径中至关重要。专有区块链解决方案与人工智能(AI)功能和边缘计算支持的结合提供了增强的隐私和安全性、改进的安全性、更好的风险管理和上级运营效率。该解决方案的功能是覆盖传统系统。它可以轻松地与云中或内部的现有信息管理系统集成。此外,该解决方案是可扩展的,为利益相关者(包括那些寻求Web 3.0向上兼容性的人)提供了竞争优势和易于采用性。 除了在这一应用领域的直接影响外,该技术还可以通过防止或减少数据泄露、提高信任和生活质量以及降低医疗保健总成本,对经济和社会产生更广泛的积极影响。SBIR第二阶段项目为高级指令和生命维持管理建立了一个新颖、高效和有效的解决方案,鉴于应用程序的高度个性化和道德复杂性,这是精准健康和医学的关键领域之一。零信任解决方案通过避免任何单点故障并保持运营效率,实现分散的机密性,细粒度的访问控制和强大的入侵容忍。通过利用现代加密协议、预构建的隐私保护智能合约、高级用户访问控制覆盖、对发布/订阅消息传递模式的支持、与链下操作的集成以及保密机器学习模型,该解决方案提供了一个独特的、模块化的、去中心化的架构,可以满足复杂的监管、隐私和安全要求。此外,该技术专为解决物联网(IoT)网络安全和大规模数据管理而设计。该项目旨在减少网络脆弱性,提高运营灵活性并实现可扩展性,这将有利于广泛的相关医疗保健和精准医学领域,如移植服务,基因组医学或生物库,其中数据保密性至关重要,特别是因为这些非常容易受到数据泄露和网络攻击。该奖项反映了NSF的法定使命,并被认为是值得的通过使用基金会的知识价值和更广泛的影响审查标准进行评估来提供支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anthony Deasey其他文献
Anthony Deasey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anthony Deasey', 18)}}的其他基金
SBIR Phase I: Blockchain-Enabled Clinical Registry Program
SBIR 第一阶段:区块链支持的临床注册计划
- 批准号:
2036317 - 财政年份:2021
- 资助金额:
$ 98.49万 - 项目类别:
Standard Grant
相似国自然基金
Fe(II)诱导铁矿物晶相重组强化土壤中镍的选择性淋洗及其机理研究
- 批准号:42307337
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
二维过渡金属硫化物合金纳米片的带隙调控及近红外II区光热性能研究
- 批准号:22005259
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
百草枯II相代谢机制及其代谢物的法医毒物动力学研究
- 批准号:82072116
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
厚度可控g-C3N4基Z-II型光催化剂的构建及电荷分离机制研究
- 批准号:22002074
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
可溶性还原态S(-II)介导下施氏矿物相转化过程及耦合重金属再分配的影响机制
- 批准号:2020A1515010539
- 批准年份:2020
- 资助金额:10.0 万元
- 项目类别:省市级项目
重电子掺杂FeSe基超导体压力诱导的超导II相研究
- 批准号:11904391
- 批准年份:2019
- 资助金额:27.0 万元
- 项目类别:青年科学基金项目
Nrf2通过端粒酶逆转录酶调控II型肺泡上皮细胞铁死亡缓解急性肺损伤的作用机制研究
- 批准号:81970065
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
铁电絮凝中固相Fe(II)活化氧气产羟自由基的规律与机制
- 批准号:51808415
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
痛经与II相代谢酶:前药理论研究桂枝茯苓胶囊作用机制
- 批准号:81773987
- 批准年份:2017
- 资助金额:55.0 万元
- 项目类别:面上项目
Nrf2在II型糖尿病引起的阿尔茨海默症的发病和治疗中的作用和机制研究
- 批准号:81703520
- 批准年份:2017
- 资助金额:20.1 万元
- 项目类别:青年科学基金项目
相似海外基金
SBIR Phase II: Innovative Glass Inspection for Advanced Semiconductor Packaging
SBIR 第二阶段:先进半导体封装的创新玻璃检测
- 批准号:
2335175 - 财政年份:2024
- 资助金额:
$ 98.49万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Intelligent Language Learning Environment
SBIR第二阶段:智能语言学习环境
- 批准号:
2335265 - 财政年份:2024
- 资助金额:
$ 98.49万 - 项目类别:
Cooperative Agreement
SBIR Phase II: FlashPCB Service Commercialization and AI Component Package Identification
SBIR第二阶段:FlashPCB服务商业化和AI组件封装识别
- 批准号:
2335464 - 财政年份:2024
- 资助金额:
$ 98.49万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Thermally-optimized power amplifiers for next-generation telecommunication and radar
SBIR 第二阶段:用于下一代电信和雷达的热优化功率放大器
- 批准号:
2335504 - 财政年份:2024
- 资助金额:
$ 98.49万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Innovative Two-Phase Cooling with Micro Closed Loop Pulsating Heat Pipes for High Power Density Electronics
SBIR 第二阶段:用于高功率密度电子产品的创新两相冷却微闭环脉动热管
- 批准号:
2321862 - 财政年份:2024
- 资助金额:
$ 98.49万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Sodium-Based Solid-State Batteries for Stationary Energy Storage
SBIR第二阶段:用于固定储能的钠基固态电池
- 批准号:
2331724 - 财政年份:2024
- 资助金额:
$ 98.49万 - 项目类别:
Cooperative Agreement
SBIR Phase II: A mesh-free, sling-free, minimally invasive treatment for stress urinary incontinence in women
SBIR II 期:无网、无吊带的微创治疗女性压力性尿失禁
- 批准号:
2233106 - 财政年份:2024
- 资助金额:
$ 98.49万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Computer-based co-reading for students with reading disabilities
SBIR 第二阶段:为有阅读障碍的学生提供基于计算机的共同阅读
- 批准号:
2321439 - 财政年份:2024
- 资助金额:
$ 98.49万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Development of a Novel Measurement Technology to Enable Longitudinal Multiomic Investigations of the Gut Microbiome
SBIR 第二阶段:开发新型测量技术以实现肠道微生物组的纵向多组学研究
- 批准号:
2314685 - 财政年份:2024
- 资助金额:
$ 98.49万 - 项目类别:
Cooperative Agreement
SBIR Phase II: High-Performance Batteries to Decarbonize Heavy Duty Construction Equipment
SBIR 第二阶段:高性能电池使重型建筑设备脱碳
- 批准号:
2335320 - 财政年份:2024
- 资助金额:
$ 98.49万 - 项目类别:
Cooperative Agreement